Bitmine Immersion Technologies

Business

ExxonMobil Launches Major Carbon Capture Hub in Louisiana, Testing Investor Confidence at $141 Share Price

ExxonMobil has commenced commercial operations at a significant carbon capture and storage (CCS) facility in Louisiana, developed in partnership with CF Industries. The move signals a strategic expansion of the oil giant's low-carbon portfolio and has sparked debate among investors weighing its long-term value against current momentum.

Feb 2, 2026

Business

Colgate-Palmolive Bets on Global Talent Rotations to Forge Its Next Generation of Leaders

With one in twelve salaried employees having worked in multiple countries, Colgate-Palmolive is leveraging international assignments as a core strategy to build agile, globally-minded leadership.

Feb 2, 2026

Business

Mobileye Eyes 2026 as Pivotal Year Amid Analyst Backing and Strategic Shifts

Despite recent guidance revisions, Mobileye Global retains strong buy ratings from analysts who see significant upside potential, as the company positions 2026 for a strategic transition in the autonomous driving sector.

Feb 2, 2026

Business

William Blair Touts Rambus as a Leading Force in the Booming DRAM Market

Investment firm William Blair has initiated coverage on Rambus Inc. with an 'Outperform' rating, highlighting the chip designer's dominant market share in interface circuits and its strategic positioning to capitalize on surging demand from AI data centers and server DRAM upgrades.

Feb 2, 2026

Business

IREN Pivots from Bitcoin Mining to AI Infrastructure with Major Microsoft, Dell Deals

Digital infrastructure firm IREN secures a landmark $9.7 billion agreement with Microsoft and a massive GPU procurement from Dell, marking a strategic shift from cryptocurrency mining to powering the AI cloud boom.

Feb 2, 2026

Business

Fidelity, Broadcom Reach Settlement in Critical Software Access Dispute

Fidelity Investments and Broadcom have settled a legal dispute that threatened Fidelity's access to business-critical software, averting a potential operational crisis. The agreement, reached just before a key court hearing, ensures continued service for a Fidelity subsidiary.

Feb 2, 2026

Business

TSMC Bets Big on AI Future with Record $56 Billion Capex Plan, Fueling Market Optimism

Taiwan Semiconductor Manufacturing Co. (TSMC) has unveiled an aggressive capital expenditure plan for 2026, signaling robust confidence in sustained demand driven by artificial intelligence and high-performance computing, which has spurred a significant rally in its shares and upward revisions from analysts.

Feb 2, 2026

Business

Baidu's Stock Surge: A 75% Annual Gain Defies Earnings Slump, Spotlighting AI Ambitions

While passive index funds track the broader market, selective stock picks can deliver outsized returns. Baidu's (NASDAQ: BIDU) shares have soared 75% in the past year, dramatically outpacing the market. This rally comes despite a significant drop in earnings, shifting investor focus towards the company's long-term strategic bets in artificial intelligence and autonomous driving.

Feb 2, 2026

Business

Beyond the Penny Label: Three TSX-Listed Small Caps With Strong Balance Sheets and Growth Ambitions

As the TSX rides a wave of broad-based earnings optimism, a closer look reveals smaller companies, often miscategorized as 'penny stocks', that combine financial resilience with clear growth trajectories. We examine three such firms with market caps up to CA$700 million.

Feb 2, 2026

Business

Beyond Nvidia: How Broadcom and TSMC Are Carving Out the Next Frontier in AI Chips

As tech giants scramble to curb soaring AI costs, a strategic pivot toward custom silicon is reshaping the competitive landscape, with Broadcom's design prowess and TSMC's manufacturing dominance creating a powerful new axis of influence.

Feb 2, 2026

Business

UiPath: From Automation Pioneer to Agentic AI Contender – Is the Pullback a Buying Opportunity?

Despite a steep decline from its highs, UiPath's pivot towards agentic AI and a path to sustained profitability is drawing investor scrutiny. We examine its valuation, competitive moat, and growth runway in a crowded field.

Feb 2, 2026

Business

Eli Lilly Bets Big on Pennsylvania with $3.5 Billion Plant for Next-Gen Weight Loss Drugs

The pharmaceutical giant's final major U.S. facility will rise in Pennsylvania's historic Lehigh Valley, aiming to produce its promising triple-hormone drug retatrutide and bolster domestic supply chains for blockbuster obesity treatments.

Feb 2, 2026

World

Berlin and Warsaw Forge Pact to Revitalize European Economy

Finance ministers from Germany and Poland have called for a joint leadership role in boosting Europe's competitiveness, citing a shifting global landscape and internal bureaucratic hurdles.

Feb 2, 2026

Business

Navigating the Downturn: Three Asset Strategies Gaining Traction Amid Market Volatility

As markets face significant pressure, certain portfolios tied to strategic commodities, resilient tech, and innovative crypto infrastructure are showing notable resilience. Analysts point to long-term thematic bets that are weathering the current storm.

Feb 2, 2026

Business

Markets Edge Lower Ahead of Key Labor Data, Earnings Deluge

U.S. stock futures pointed to a lower open Monday as investors braced for a flood of corporate earnings and crucial labor market reports that could sway Federal Reserve policy expectations.

Feb 2, 2026

Business

Visa and Mastercard Post Strong Quarterly Gains, Fueling Debate Over Long-Term Value

The payments giants Visa and Mastercard reported robust revenue and earnings growth for their latest quarters, though their premium valuations continue to spark investor debate on which offers the superior long-term opportunity.

Feb 2, 2026

Business

Essar Commits $100 Million to Boost Gas Output from Key Indian CBM Field

Essar Oil and Gas Exploration & Production (EOGEPL) is injecting $100 million into its flagship Raniganj East CBM block in West Bengal, aiming to scale up domestic natural gas production and explore shale potential in a bid to reduce India's import reliance.

Feb 2, 2026

Business

Rhythm Pharmaceuticals: The Under-the-Radar Biotech Outpacing Tech Giants

While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.

Feb 2, 2026

Business

EyePoint's Stock Soars 195% in Three Years Despite Persistent Losses, Sparking Investor Debate

While EyePoint Pharmaceuticals (EYPT) shares have retreated 23% this month, long-term shareholders are still sitting on massive gains. The biotech's 195% three-year surge, despite ongoing losses, highlights a classic market puzzle: balancing current financials with future potential.

Feb 2, 2026

Business

Three Sub-$50 Stocks That Warrant Investor Skepticism

While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, their low price tags can sometimes mask underlying vulnerabilities. We examine three such companies where caution may be prudent.

Feb 2, 2026